Boston Scientific AGENT
Coronary paclitaxel DCB with FDA approval for in-stent restenosis.
Specifications
| Manufacturer | Boston Scientific — USA |
|---|---|
| Drug | Paclitaxel 2 µg/mm² |
| Main indication | Coronary in-stent restenosis |
| Procedures | PCI |
Specifications are compiled from public manufacturer information for education only. Always verify against the current IFU and the version registered in your country before clinical use.
Related products
B. BraunDrug-coated balloons (DCB)
SeQuent Please NEO
Paclitaxel DCB with one of the longest evidence records in in-stent restenosis.
Drug: Paclitaxel 3 µg/mm²
B. BraunDrug-coated balloons (DCB)
SeQuent SCB
New-generation sirolimus-coated balloon.
Drug: Sirolimus
Concept MedicalDrug-coated balloons (DCB)
MagicTouch
Sirolimus DCB using nanocarrier technology.
Drug: Sirolimus (nanocarrier)
BiotronikDrug-coated balloons (DCB)
Pantera Lux
German paclitaxel-coated balloon.
Drug: Paclitaxel 3 µg/mm²